Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.

The New England journal of medicine - 12 Nov 2015

Bloemberg Guido V, Keller Peter M, Stucki David, Stuckia David, Trauner Andrej, Borrell Sonia, Latshang Tsogyal, Coscolla Mireia, Rothe Thomas, Hömke Rico, Ritter Claudia, Feldmann Julia, Schulthess Bettina, Gagneux Sebastien, Böttger Erik C

Abstract excerpt

Treatment of multidrug-resistant Mycobacterium tuberculosis is a challenge. This letter describes the emergence of resistance to new therapies, bedaquiline and delamanid.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Diarylquinolines
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Mycobacterium tuberculosis

Share to Nitroimidazoles

Share to Oxazoles

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 26559594
DOI: 10.1056/NEJMc1505196
PMCID: PMC4681277

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.PMID 26559594Read ↗

Delamanid Resistance: Update and Clinical ManagementSemantic proximity Read ↗

Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in ChinaSemantic proximity Read ↗

Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysisSemantic proximity Read ↗

Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.Semantic proximity Read ↗

Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid.Semantic proximity Read ↗

Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in KoreaSemantic proximity Read ↗

Spontaneous Mutational Patterns and Novel Mutations for Delamanid Resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Totally drug-resistant tuberculosis and adjunct therapies.Semantic proximity Read ↗

Spontaneous mutations to delamanid and pretomanid resistance in Mycobacterium tuberculosis: SNPs confer high-level resistance.Semantic proximity Read ↗

Delamanid or pretomanid for treatment of multidrug resistant tuberculosis---spoilt for choice?Semantic proximity Read ↗

Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran.Semantic proximity Read ↗

Whole-Genome Sequencing and Phenotypic Drug Susceptibility Testing of Bedaquilin, Delamanid, Pretomanid, and Linezolid in Drug-Resistant Mycobacterium tuberculosis from a Single Institute in South Korea.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.